Popular Articles From: Amgen And Onyx Announce Detailed Results From Phase 3 ASPIRE Study Of Kyprolis® (Carfilzomib) In Patients With Relapsed Multiple Myeloma to Tiptree Financial Inc. and Fortegra Financial Corporation Complete Merger


2014/12/6
Data From Pivotal Trial Published in the New England Journal of Medicine and Presented at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition Overall Response Rate, Duration of Response, Health-Related Quality of Life Secondary Endpoints Met; Overall Survival Continues to be Monitored Results to be Presented During an Oral Session at ASH on Sunday, December 7 at 12 p.m. PT Data to be Featured in ASH Press Briefing on Saturday, December 6 at 8 a.m. PT THOUSAND OAKS, Calif.
Sign-up for Amgen And Onyx Announce Detailed Results From Phase 3 ASPIRE Study Of Kyprolis® (Carfilzomib) In Patients With Relapsed Multiple Myeloma investment picks
2014/12/6
78 Percent of Patients Treated With BLINCYTO Experienced a Complete Minimal Residual Disease (MRD) Response After One Treatment Cycle Results to be Presented During an Oral Session at the American Society of Hematology (ASH) 56th Annual Meeting and Exposition on Monday, December 8 at 10:30 a.m. PT Data to be Featured in ASH Press Briefing on Saturday, December 6 at 10 a.m. PT THOUSAND OAKS, Calif.
Sign-up for Amgen Announces New Data From Phase 2 BLINCYTO™ (blinatumomab) Immunotherapy Study In Patients With Acute Lymphoblastic Leukemia And Minimal Residual Disease investment picks
2014/12/6
Bristol-Myers Squibb Company (NYSE:BMY) today announced positive results from a cohort of patients in its ongoing Phase 1b trial (CheckMate -039) which evaluated PD-1 immune checkpoint inhibitor, Opdivo (nivolumab), in patients with relapsed or refractory hematological malignancies (n=23). Results showed high levels of response in patients with relapsed or refractory classical Hodgkin Lymphoma (HL), with an overall response rate of 87% (n=20) and stable disease in 13% (n=3). These findings were published today in The New England Journal of Medicine ( NEJM ) and highlighted in the press briefing on Saturday, December 6 during the 56 th annual meeting of the American Society for Hematology (Abstract #289). In patients with HL, initial treatment typically consists of chemotherapy and/or radiation therapy, followed by an autologous stem cell
Sign-up for Opdivo (nivolumab) Demonstrates High Overall Response Rate of 87% for Treatment of Relapsed or Refractory Hodgkin Lymphoma investment picks
2014/12/5
By Robb M.
Sign-up for Bain, Pacific Equity Partners make offer for Bradken investment picks
2014/12/5
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1163151&ProfileId=051205&sourceType=1 SAN FRANCISCO, CA and LONDON, UNITED KINGDOM --
Sign-up for Sweden's Largest Private Health and Dental Provider Chooses Advent Software to Support Its Pension Fund investment picks
2014/12/5
A large selection of construction and transportation equipment items will be sold for dozens of owners, including Equipment World's 2014 Contractor of the Year, Jeremy Hiltz Excavating Inc. MANCHESTER, NH , Dec.
Sign-up for Ritchie Bros. to conduct unreserved public auction in Manchester, New Hampshire on December 12 investment picks
2014/12/5
Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) today announced the completion of its acquisition of Bode Technology Group, Inc., (Bode Technology) from SolutionPoint International, Inc. As a wholly-owned subsidiary of LabCorp, Bode Technology and its division Chromosomal Labs will continue to provide specialized forensic DNA analysis, proprietary DNA collection products, and relationship testing to an international market in combination with LabCorp’s US- and UK-based DNA Identity and Cellmark Forensics businesses, part of LabCorp’s Specialty Testing Group.
Sign-up for LabCorp Announces Acquisition of Bode Technology investment picks
2014/12/5
For a third straight year, TD Ameritrade Institutional 1 earned the highest marks among registered investment advisor (RIA) custodians for overall technology satisfaction in Financial Planning magazine’s annual Financial Planning Tech Survey.
Sign-up for TD Ameritrade Institutional Technology Tops Financial Planning's Advisor Satisfaction Survey for Third Straight Year investment picks
2014/12/5
SOUTHLAKE, Texas, Dec.
Sign-up for Del Frisco's Restaurant Group Ranked No. 3 in The Dallas Morning News' 2014 Top 100 Places to Work investment picks
2014/12/5
MINNEAPOLIS , Dec.
Sign-up for CHS: Driving Momentum to help farmer-owners grow investment picks
2014/12/5
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1163356&ProfileId=051205&sourceType=1 ZEELAND, MI --
Sign-up for Gentex Corporation Declares 100% Stock Dividend and Announces Share Repurchases of $20 Million investment picks
2014/12/5
OKLAHOMA CITY, Dec.
Sign-up for Paycom Releases Dashboard Enhancement to Its ACA Compliance Solutions investment picks
2014/12/5
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1163423&ProfileId=051205&sourceType=1 MANISTIQUE, MI --
Sign-up for Mackinac Financial Corporation Completes the Acquisition of Peninsula Financial Corporation investment picks
2014/12/5
National Health Investors, Inc. (NYSE:NHI) (the “Company” or “NHI”) announced today the completion of its public offering of 4,427,500 shares of its common stock, including 577,500 shares issued pursuant to the exercise in full of the underwriters’ option to purchase additional shares, at a price to the public of $63.80 per share.
Sign-up for NHI Completes Offering of 4,427,500 Shares of Common Stock investment picks
2014/12/5
The Empire District Electric Company (NYSE:EDE) announced today that it has filed a request with the Kansas Corporation Commission to implement an Environmental Cost Recovery Rider for costs associated with new environmental facilities installed at its Asbury generating unit.
Sign-up for The Empire District Electric Company Files Kansas Environmental Cost Recovery Rider investment picks
2014/12/5
The board of directors of Strategic Global Income Fund, Inc. (NYSE:SGL) (the “Fund”) has set Friday, January 16, 2015, as the record date for determination of the shareholders entitled to vote at the Fund's annual meeting of shareholders, to be held on Thursday, March 12, 2015.
Sign-up for Strategic Global Income Fund, Inc. – Announces Record Date for 2015 Annual Meeting of Shareholders investment picks
2014/12/5
RLI Corp.
Sign-up for RLI Announces Leadership Promotions investment picks
2014/12/4
CoreSite Realty Corporation (NYSE:COR), a premier provider of secure, reliable, high-performance data center solutions across the US, today announced that the AMS-IX USA Inc., a subsidiary of AMS-IX (Amsterdam Internet Exchange) in Amsterdam, has established an AMS-IX Bay Area Point-of-Presence (PoP) in CoreSite’s Silicon Valley market.
Sign-up for AMS-IX Expands Presence to CoreSite’s Silicon Valley Market investment picks
2014/12/4
European supply chain and logistics leader finds that Forward! platform's fabric architecture and secure partitioning deliver superior performance, better security and lower cost than standard virtualization LONDON , Dec.
Sign-up for P&O Ferrymasters Selects Forward! by Unisys Platform to Power Its Mission-Critical Freight Management System investment picks
2014/12/4
HOFFMAN ESTATES, Ill.
Sign-up for Sears Holdings Reports Third Quarter 2014 Results investment picks
2014/12/4
Extending its commitment to provide "best-in-class" health and wellness products, Gaiam now offers the posture-perfecting Lumo Lift NEW YORK , Dec.
Sign-up for Gaiam Enters Wearable Technology Space With Lumo Lift investment picks
2014/12/4
Engility Holdings, Inc. (NYSE: EGL) today announced its receipt of notice from the Federal Trade Commission of the early termination of the required waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”) with respect to Engility’s proposed acquisition of TASC.
Sign-up for Engility Announces Early Termination of Hart-Scott-Rodino Waiting Period for Proposed Acquisition of TASC investment picks
2014/12/4
One year ago Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW), was receiving numerous registrations around the globe for Isoclast™ Active (sulfoxaflor), the company’s newest insecticide offering for the global agricultural marketplace.
Sign-up for 2014 a Significant Year for Isoclast™ Active Insecticide investment picks
2014/12/4
Liberty Broadband Corporation (“Liberty Broadband”) (Nasdaq: LBRDA, LBRDK) announced today that it has determined the per share subscription price, commencement date and expiration date for its previously announced rights offering.
Sign-up for Liberty Broadband Corporation Announces Terms of Rights Offering investment picks
2014/12/4
MCLEAN, Va.
Sign-up for Capital One And Hudson's Bay Company Announce New Credit Card Program Agreement investment picks
2014/12/4
Admissions have now gone on sale as Wizard World, Inc. (OTCBB: WIZD) continues its 2015 schedule with its first trip to the Las Vegas Convention Center at Wizard World Las Vegas Comic Con, April 24-26.
Sign-up for Admissions Now On Sale For Inaugural Wizard World Las Vegas Comic Con Featuring Norman Reedus, Tom Felton, Michael Rooker, Seth Gilliam, April 24-26, 2015 investment picks
2014/12/4
Tiptree Financial Inc. (NASDAQ:TIPT) (“Tiptree”) and Fortegra Financial Corporation (“Fortegra”) announced today completion of the previously announced merger of Fortegra into a subsidiary of Tiptree for approximately $218 million in cash.
Sign-up for Tiptree Financial Inc. and Fortegra Financial Corporation Complete Merger investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Popular Articles From: Amgen And Onyx Announce Detailed Results From Phase 3 ASPIRE Study Of Kyprolis® (Carfilzomib) In Patients With Relapsed Multiple Myeloma to Tiptree Financial Inc. and Fortegra Financial Corporation Complete Merger
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent